Antibiotic-Killed Staphylococcus aureus Induces Destructive Arthritis in Mice

被引:39
|
作者
Ali, Abukar [1 ]
Zhu, Xuefeng [1 ]
Kwiecinski, Jakub [1 ]
Gjertsson, Inger [1 ]
Lindholm, Catharina [1 ]
Iwakura, Yoichiro [2 ]
Wang, Xiaoyang [1 ]
Lycke, Nils [1 ]
Josefsson, Elisabet [1 ]
Pullerits, Rille [1 ]
Jin, Tao [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, S-41346 Gothenburg, Sweden
[2] Tokyo Univ Sci, Chiba, Japan
基金
英国医学研究理事会;
关键词
TUMOR-NECROSIS-FACTOR; CELL WALL COMPONENTS; SEPTIC ARTHRITIS; BACTERIAL-DNA; DEXAMETHASONE THERAPY; SYNOVIAL-FLUID; IMMUNE-SYSTEM; DOUBLE-BLIND; TNF-ALPHA; RECEPTOR;
D O I
10.1002/art.38902
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Permanent reduction in joint function is a severe postinfectious complication in patients with Staphylococcus aureus septic arthritis. We undertook this study to determine whether this reduction in joint function might be caused by persistent joint inflammation after the adequate eradication of bacteria by antibiotics. Methods. After intraarticular injection of cloxacillin-killed S aureus into mouse knee joints, we investigated whether antibiotic-killed S aureus induced joint inflammation and elucidated the molecular and cellular mechanisms of this type of arthritis. Results. Intraarticular injection of antibiotic-killed S aureus induced mild-to-moderate synovitis and bone erosions that lasted for a minimum of 14 days. Compared with wild-type animals, mice deficient in tumor necrosis factor receptor type I (TNFRI), receptor for advanced glycation end products (RAGE), or Toll-like receptor 2 (TLR-2) had a significantly reduced frequency and severity of synovitis. Combined depletion of monocytes and neutrophils also resulted in a significantly lower frequency of synovitis. Among bacterial factors, insoluble cell debris played a more important role than bacterial DNA or soluble components in inducing joint inflammation. Importantly, anti-TNF therapy abrogated joint inflammation induced by antibiotic-killed S aureus. Conclusion. Antibiotic-killed S aureus induced and maintained joint inflammation mediated through TLR-2, TNFRI, and RAGE. The cross-talk between neutrophils and monocytes is responsible for this type of arthritis. Anti-TNF therapy might be used as a novel strategy, in combination with antibiotics, to treat staphylococcal septic arthritis.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 50 条
  • [41] Antibiotic combinations reduce Staphylococcus aureus clearance
    Viktória Lázár
    Olga Snitser
    Daniel Barkan
    Roy Kishony
    Nature, 2022, 610 : 540 - 546
  • [42] Antibiotic combinations reduce Staphylococcus aureus clearance
    Lazar, Viktoria
    Snitser, Olga
    Barkan, Daniel
    Kishony, Roy
    NATURE, 2022, 610 (7932) : 540 - +
  • [43] Waves of resistance: Staphylococcus aureus in the antibiotic era
    Henry F. Chambers
    Frank R. DeLeo
    Nature Reviews Microbiology, 2009, 7 : 629 - 641
  • [44] MODE OF ACTION OF ANTIBIOTIC PAROMOMYCIN ON STAPHYLOCOCCUS AUREUS
    VONSEEFRIED, A
    JORDAN, DC
    CANADIAN JOURNAL OF MICROBIOLOGY, 1966, 12 (06) : 1157 - +
  • [45] ANTIBIOTIC-TOLERANT STAPHYLOCOCCUS-AUREUS
    WATANAKUNAKORN, C
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (06) : 561 - 568
  • [46] ANTIBIOTIC TOLERANCE IN STRAINS OF STAPHYLOCOCCUS-AUREUS
    NORDEN, CW
    KELETI, E
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 7 (06) : 599 - 605
  • [47] STAPHYLOCOCCUS-AUREUS ANTIBIOTIC-RESISTANCE
    PEGRAM, PS
    AMERICAN FAMILY PHYSICIAN, 1981, 24 (03) : 165 - 170
  • [48] Waves of resistance: Staphylococcus aureus in the antibiotic era
    Chambers, Henry F.
    DeLeo, Frank R.
    NATURE REVIEWS MICROBIOLOGY, 2009, 7 (09) : 629 - 641
  • [49] Staphylococcus aureus resistant to powerful new antibiotic
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2001, 132 (09): : 1218 - 1218
  • [50] Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus
    Monaco, Monica
    de Araujo, Fernanda Pimentel
    Cruciani, Melania
    Coccia, Eliana M.
    Pantosti, Annalisa
    STAPHYLOCOCCUS AUREUS: MICROBIOLOGY, PATHOLOGY, IMMUNOLOGY, THERAPY AND PROPHYLAXIS, 2017, 409 : 21 - 56